Who invested in Siren Biotechnology

2 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 5 months ago

Funding summaryUpdated 26 Oct 2026

$8.0Mraised across 2 rounds since 2024, from 2 sources

Latest round: Grant, $8.0MJun 2026
Investors: 5

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20252026

?Venture$8.0MGrant

First round: Venture
Biggest round: $8.0M
Between rounds: 2 years

The rounds

Jun 2026
Grant$8.0M4 returning
Source recorded
Jun 2024
VentureAmount undisclosed5 new
Source recordedSEC filing: $20M sold, first sale Apr 2024

Founders and team

From Siren Biotechnology's own website and the SEC filings it signed: 5 on the team.

Christopher NovashinskiHead of Regulatory
Tracy TreDenick-FrickeHead of Quality
Clinical LeadDirector of Translational Research
Ford H-KirschenbaumScientist - Translational Research
Nicole PaulkExecutive Officer, Directori

On the board, as filediBrad AllenSharon Tetlow

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Venture2024Grant2026

Everyone who backed them

Founders FundVC firm2rounds

Lux CapitalVC firm2rounds

Innovation EndeavorsVC firm2rounds

Artis Ventures (AV)VC firm2rounds

NZVCVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 3 firms list Siren Biotechnology as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.